A detailed history of Convergence Financial, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Convergence Financial, LLC holds 1,949 shares of ZTS stock, worth $344,407. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,949
Previous 2,323 16.1%
Holding current value
$344,407
Previous $403 Million 5.44%
% of portfolio
0.08%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$172.58 - $196.48 $64,544 - $73,483
-374 Reduced 16.1%
1,949 $381 Million
Q2 2024

Oct 23, 2024

BUY
$145.54 - $178.83 $338,089 - $415,422
2,323 New
2,323 $403 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Convergence Financial, LLC Portfolio

Follow Convergence Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Financial, LLC with notifications on news.